Positive Airway Pressure Therapy Initiation and Continued Benzodiazepine Use Among Chronic Drug Users
Abstract Treating obstructive sleep apnea (OSA) has been shown to improve concomitant insomnia symptoms, but whether treating OSA translates into reducing sedative medication use is unknown. We evaluated the association between initiating incident positive airway pressure (PAP) therapy and continued benzodiazepine drug receipt among chronic benzodiazepine users. This was a retrospective, population‐based cohort study, analysing Ontario health administrative data from January 1, 2012–March 31, 2020. Persons aged 18 years and older, who were chronic benzodiazepine users, were included. The association
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
